Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Vogt

Showing results (231-240 of 291) with videos related to

Pageof 30
Sort By:
The Journal of Investigative Dermatology|June 17, 2006
High frequency of FGFR3 mutations in adenoid seborrheic keratosesChristian Hafner, Johanna M M van Oers, Arndt Hartmann, et al.
The Journal of Clinical Investigation|July 15, 2006
Mosaicism of activating FGFR3 mutations in human skin causes epidermal neviChristian Hafner, Johanna M M van Oers, Thomas Vogt, et al.
SSM - Population Health|February 14, 2023
Multifaceted determinants of social-emotional problems in preschool children in Sweden: An ecological systems theory approachMasoud Vaezghasemi, Thomas Vogt, Marie Lindkvist, et al.
Frontiers in Cellular and Infection Microbiology|March 21, 2024
The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesionsLuca Vella, Anna Sternjakob, Stefan Lohse, et al.
Anticancer Research|October 3, 2022
An Appraisal to Address Health Consequences of Vitamin D Deficiency With Food Fortification and Supplements: Time to Act!Jörg Reichrath, Winfried März, Frank R DE Gruijl, et al.
Melanoma Research|November 10, 2007
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trialAlbrecht Reichle, Thomas Vogt, Brigitte Coras, et al.
Experimental Dermatology|May 27, 2010
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanomaStefanie Meyer, Peter J Wild, Thomas Vogt, et al.
Chemistry of Materials : a Publication of the American Chemical Society|May 13, 2022
Oxide Ion Conductivity, Proton Conductivity, and Phase Transitions in Perovskite-Derived Ba<sub>3-</sub> Sr <sub></sub> YGa<sub>2</sub>O<sub>7.5</sub> 0 ≤ <i>x</i> ≤ 3 MaterialsChloe A Fuller, James Iain Murrell, Douglas A Blom, et al.
Pharmaceutics|December 1, 2020
Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin DiseasesRebekka Christmann, Duy-Khiet Ho, Jenny Wilzopolski, et al.
Anticancer Research|January 29, 2018
Solarium Use and Risk for Malignant Melanoma: Meta-analysis and Evidence-based Medicine Systematic ReviewBarbara Burgard, Jakob Schöpe, Isabel Holzschuh, et al.
Pageof 30

Showing results (231-240 of 291) with videos related to

Sort By:
Pageof 30
The Journal of Investigative Dermatology|June 17, 2006
High frequency of FGFR3 mutations in adenoid seborrheic keratosesChristian Hafner, Johanna M M van Oers, Arndt Hartmann, et al.
The Journal of Clinical Investigation|July 15, 2006
Mosaicism of activating FGFR3 mutations in human skin causes epidermal neviChristian Hafner, Johanna M M van Oers, Thomas Vogt, et al.
SSM - Population Health|February 14, 2023
Multifaceted determinants of social-emotional problems in preschool children in Sweden: An ecological systems theory approachMasoud Vaezghasemi, Thomas Vogt, Marie Lindkvist, et al.
Frontiers in Cellular and Infection Microbiology|March 21, 2024
The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesionsLuca Vella, Anna Sternjakob, Stefan Lohse, et al.
Anticancer Research|October 3, 2022
An Appraisal to Address Health Consequences of Vitamin D Deficiency With Food Fortification and Supplements: Time to Act!Jörg Reichrath, Winfried März, Frank R DE Gruijl, et al.
Melanoma Research|November 10, 2007
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trialAlbrecht Reichle, Thomas Vogt, Brigitte Coras, et al.
Experimental Dermatology|May 27, 2010
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanomaStefanie Meyer, Peter J Wild, Thomas Vogt, et al.
Chemistry of Materials : a Publication of the American Chemical Society|May 13, 2022
Oxide Ion Conductivity, Proton Conductivity, and Phase Transitions in Perovskite-Derived Ba<sub>3-</sub> Sr <sub></sub> YGa<sub>2</sub>O<sub>7.5</sub> 0 ≤ <i>x</i> ≤ 3 MaterialsChloe A Fuller, James Iain Murrell, Douglas A Blom, et al.
Pharmaceutics|December 1, 2020
Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin DiseasesRebekka Christmann, Duy-Khiet Ho, Jenny Wilzopolski, et al.
Anticancer Research|January 29, 2018
Solarium Use and Risk for Malignant Melanoma: Meta-analysis and Evidence-based Medicine Systematic ReviewBarbara Burgard, Jakob Schöpe, Isabel Holzschuh, et al.
Pageof 30